logo

Regulus Therapeutics Inc. (RGLS)



Trade RGLS now with
  Date
  Headline
3/18/2019 8:03:38 AM  Regulus Therapeutic Q4 Net Loss $8.6 Mln Vs. Net Loss Of $14.4 Mln Prior Year
1/7/2019 8:22:01 AM Regulus Therapeutics Announces Nomination Of RGLS5579 As Clinical Candidate For Treatment Of Glioblastoma Multiforme
10/9/2018 4:59:52 PM Wedbush Is Lowering Regulus Therapeutics Inc. (RGLS) 2019 Estimate To -2.82 From -0.24
10/9/2018 4:59:36 PM Wedbush Is Cutting Regulus Therapeutics Inc. (RGLS) 4Q19 Estimate To -0.74 From -0.06
10/9/2018 4:59:12 PM Wedbush Is Lowering Regulus Therapeutics Inc. (RGLS) 3Q19 Estimate To -0.72 From -0.06
10/9/2018 4:59:02 PM Wedbush Is Lowering Regulus Therapeutics Inc. (RGLS) 2Q19 Estimate To -0.69 From -0.06
10/9/2018 4:58:38 PM Wedbush Is Lowering Regulus Therapeutics Inc. (RGLS) 1Q19 Estimate To -0.67 From -0.06
10/9/2018 4:58:16 PM Wedbush Is Lowering Regulus Therapeutics Inc. (RGLS) 2018 Estimate To -1.02 From -0.41
10/9/2018 4:55:24 PM Wedbush Is Lowering Regulus Therapeutics Inc. (RGLS) 4Q18 Estimate To -0.67 From -0.06
10/4/2018 8:05:49 AM Regulus Therapeutics Announces 1-for-12 Reverse Stock Split
8/9/2018 9:49:19 PM Wedbush Reiterates Regulus Therapeutics Inc. (RGLS) At Neutral With $1.00 Price Target
7/10/2018 6:35:22 AM Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) FY19 Estimate To -0.26 From -0.60
7/10/2018 6:34:59 AM Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) Q4 19 Estimate To -0.07 From -0.16
7/10/2018 6:34:50 AM Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) Q3 19 Estimate To -0.07 From -0.15
7/10/2018 6:34:37 AM Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q2 19 Estimate To -0.06 From -0.15
7/10/2018 6:31:24 AM Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) Q1 19 Estimate To -0.06 From -0.14